Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2478419rdf:typepubmed:Citationlld:pubmed
pubmed-article:2478419lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C0032136lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C0033621lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C1522240lld:lifeskim
pubmed-article:2478419lifeskim:mentionsumls-concept:C1521871lld:lifeskim
pubmed-article:2478419pubmed:issue1lld:pubmed
pubmed-article:2478419pubmed:dateCreated1989-12-12lld:pubmed
pubmed-article:2478419pubmed:abstractTextWe have constructed multicistronic vectors containing the cDNAs for murine dihydrofolate reductase (DHFR), hygromycin phosphotransferase (HyPR), and human protein C (HPC), an antithrombotic factor. Using a sequential selection protocol with hygromycin (Hy) and methotrexate (MTX), we demonstrate the selective amplification of the murine dhfr cDNA in the adenovirus-transformed human kidney cell line 293, and the coamplification of the cDNA for HPC. Such recombinant 293 cell lines secreted HPC at levels as high as 25 micrograms/10(6) cells/day. In addition, we found that the complex vitamin K-dependent posttranslational modification of gamma-carboxylation of glutamate was not limiting at these high secretion levels, although the proteolytic processing of the protein was slightly reduced. Further, the HPC secreted from the gene-amplified cell lines had full anticoagulant activity when compared to plasma-derived HPC.lld:pubmed
pubmed-article:2478419pubmed:languageenglld:pubmed
pubmed-article:2478419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:citationSubsetIMlld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2478419pubmed:statusMEDLINElld:pubmed
pubmed-article:2478419pubmed:monthSeplld:pubmed
pubmed-article:2478419pubmed:issn0378-1119lld:pubmed
pubmed-article:2478419pubmed:authorpubmed-author:YapS HSHlld:pubmed
pubmed-article:2478419pubmed:authorpubmed-author:GrinnellB WBWlld:pubmed
pubmed-article:2478419pubmed:authorpubmed-author:BergD TDTlld:pubmed
pubmed-article:2478419pubmed:authorpubmed-author:WallsJ DJDlld:pubmed
pubmed-article:2478419pubmed:issnTypePrintlld:pubmed
pubmed-article:2478419pubmed:day1lld:pubmed
pubmed-article:2478419pubmed:volume81lld:pubmed
pubmed-article:2478419pubmed:ownerNLMlld:pubmed
pubmed-article:2478419pubmed:authorsCompleteYlld:pubmed
pubmed-article:2478419pubmed:pagination139-49lld:pubmed
pubmed-article:2478419pubmed:dateRevised2006-5-1lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:meshHeadingpubmed-meshheading:2478419-...lld:pubmed
pubmed-article:2478419pubmed:year1989lld:pubmed
pubmed-article:2478419pubmed:articleTitleAmplification of multicistronic plasmids in the human 293 cell line and secretion of correctly processed recombinant human protein C.lld:pubmed
pubmed-article:2478419pubmed:affiliationDepartment of Molecular Biology, Lilly Research Laboratories, Indianapolis, IN 46285.lld:pubmed
pubmed-article:2478419pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2478419lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2478419lld:pubmed